Thomas H. Oliphant

Linezolid (PNU-100766) versus Vancomycin in the Treatment of Hospitalized Patients with Nosocomial Pneumonia: A Randomized, Double-Blind, Multicenter Study

Eric Rubinstein, Sue Cammarata, Thomas H. Oliphant et al. · Clinical Infectious Diseases · 2001 · 441 citations

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

Richard G. Wunderink, Sue Cammarata, Thomas H. Oliphant et al. · Clinical Therapeutics · 2003 · 231 citations

Antimicrobial Stewardship, Antibiotics, Klebsiella Pneumoniae +9

Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies

Ethan Rubinstein, Raúl Istúriz, Harold C. Standiford et al. · Antimicrobial Agents and Chemotherapy · 2003 · 176 citations · Full text

Drug Safety, Worldwide Assessment, Community-acquired Pneumonia +14

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler et al. · Gastroenterology · 2021 · 167 citations · Full text

Food Intolerance, Autoimmune Disease, Allergy +6

Linezolid Versus Ceftriaxone/Cefpodoxime in Patients Hospitalized for the Treatment of Streptococcus pneumoniae Pneumonia

Gerry S. San Pedro, Sue Cammarata, Thomas H. Oliphant et al. · Scandinavian Journal of Infectious Diseases · 2002 · 68 citations

Klebsiella Pneumoniae, S. Pneumoniae, Drug Resistance +20